News

Recursion Pharmaceuticals Stock Gains on Plans to Buy Drug-Development Interest from Rallybio
Shares of Recursion Pharmaceuticals climbed after the company said it has agreed to purchase Rallybio's interest in a drug-development plan that aims to treat a rare genetic bone disease. The stock ...
Recursion to buy Rallybio’s ownership in jointly developed bone disorder drug
Rallybio (NASDAQ:RLYB) shares climbed ~114% in the premarket on Tuesday after the company announced an agreement to sell its ...